START & Sarah Cannon Partner to Advance Therapies for Patients with Cancer

SAN ANTONIO, TEXAS: January 16, 2018 – South Texas Research Accelerated Therapeutics (START) and Sarah Cannon Research Institute announced today a new collaboration to complement and enhance their globally recognized phase I drug development programs. START and Sarah Cannon are each renowned leaders in the field of early phase oncology clinical trials, particularly first-in-human studies. …Read More »